{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:54:48Z","timestamp":1787871288317,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["AZ180035"],"award-info":[{"award-number":["AZ180035"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH1910698"],"award-info":[{"award-number":["W81XWH1910698"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbi.2024.09.006","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T17:09:41Z","timestamp":1725469781000},"page":"64-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Chronic glial activation and behavioral alterations induced by acute\/subacute pioglitazone treatment in a mouse model of traumatic brain injury"],"prefix":"10.1016","volume":"123","author":[{"given":"L. Daniel","family":"Estrella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Manganaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexi","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nashanthea","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin D.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Emanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin G","family":"Lamberty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7444-4403","authenticated-orcid":false,"given":"Kelly L.","family":"Stauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.rehab.2015.09.002","article-title":"Neurobehavioral and self-awareness changes after traumatic brain injury: Towards new multidimensional approaches","volume":"59","author":"Arnould","year":"2016","journal-title":"Ann. Phys. Rehabil. Med."},{"issue":"5","key":"10.1016\/j.bbi.2024.09.006_b0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2021.05.025","article-title":"Traumatic brain injury and risk of neurodegenerative disorder","volume":"91","author":"Brett","year":"2022","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2024.09.006_b0020","article-title":"Histological quantitation of brain injury using whole slide imaging: A pilot validation study in mice","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0030","doi-asserted-by":"crossref","first-page":"13646","DOI":"10.1038\/s41598-019-49428-y","article-title":"Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats","volume":"9","author":"Das","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbi.2024.09.006_b0035","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-160656","article-title":"Improved brain insulin\/IGF signaling and reduced neuroinflammation with T3D\u2013959 in an experimental model of sporadic Alzheimer\u2019s disease","volume":"55","author":"De La Monte","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"2","key":"10.1016\/j.bbi.2024.09.006_b0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.gendis.2019.05.002","article-title":"Pioglitazone ameliorates neuronal damage after traumatic brain injury via the PPAR\u03b3\/NF-\u03baB\/IL-6 signaling pathway","volume":"7","author":"Deng","year":"2020","journal-title":"Genes Dis."},{"issue":"47","key":"10.1016\/j.bbi.2024.09.006_b0045","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1523\/JNEUROSCI.2153-12.2012","article-title":"Cognitive enhancement with rosiglitazone links the hippocampal PPAR\u03b3 and ERK MAPK signaling pathways","volume":"32","author":"Denner","year":"2012","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2024.09.006_b0050","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/1570159X19666211109141330","article-title":"Advances in PPARs molecular dynamics and glitazones as a repurposingtherapeutic strategy through mitochondrial redox dynamics againstneurodegeneration","volume":"20","author":"Durai","year":"2022","journal-title":"Curr. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.bbi.2024.09.006_b0060","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/npp.2010.32","article-title":"Rosiglitazone rescues memory impairment in Alzheimer\u2019s transgenic mice: mechanisms involving a reduced amyloid and tau pathology","volume":"35","author":"Escribano","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2024.09.006_b0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2017.07.004","article-title":"Comparable impediment of cognitive function in female and male rats subsequent to daily administration of haloperidol after traumatic brain injury","volume":"296","author":"Free","year":"2017","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12974-022-02398-x","article-title":"PD-L1 signaling in reactive astrocytes counteracts neuroinflammation and ameliorates neuronal damage after traumatic brain injury","volume":"19","author":"Gao","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2024.09.006_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.831825","article-title":"Hyperacute excitotoxic mechanisms and synaptic dysfunction involved in traumatic brain injury","volume":"15","author":"Hoffe","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2024.09.006_b0095","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10072-011-0774-2","article-title":"The PPAR\u03b3 agonist rosiglitazone prevents cognitive impairment by inhibiting astrocyte activation and oxidative stress following pilocarpine-induced status epilepticus","volume":"33","author":"Hong","year":"2012","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.bbi.2024.09.006_b0100","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1006\/exnr.2001.7820","article-title":"Regional vulnerability after traumatic brain injury: Gender differences in mice that overexpress human copper, zinc superoxide dismutase","volume":"172","author":"Igarashi","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2024.09.006_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2014.00065","article-title":"Physiological and pathological phosphorylation of tau by Cdk5","volume":"7","author":"Kimura","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbi.2024.09.006_b0120","first-page":"4367","article-title":"The resident-intruder paradigm: A standardized test for aggression, violence and social stress","volume":"77","author":"Koolhaas","year":"2013","journal-title":"J. vis. Exp."},{"key":"10.1016\/j.bbi.2024.09.006_b0125","doi-asserted-by":"crossref","unstructured":"Kumar, A.P., P.P., Kumar, B.R.P., Jeyarani, V., Dhanabal, S.P., Justin, A. (2021). Glitazones, PPAR-\u03b3 and neuroprotection. Mini-Rev. Med. Chem., 21(12), 1457\u20131464. 10.2174\/1389557521666210304112403.","DOI":"10.2174\/1389557521666210304112403"},{"issue":"12","key":"10.1016\/j.bbi.2024.09.006_b0130","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.3390\/ijms241210106","article-title":"Long-term pioglitazone treatment has no significant impact on microglial activation and Tau pathology in P301S mice","volume":"24","author":"Kunze","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegen."},{"issue":"3","key":"10.1016\/j.bbi.2024.09.006_b0140","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11682-015-9414-4","article-title":"Anhedonia in combat veterans with penetrating head injury","volume":"9","author":"Lewis","year":"2015","journal-title":"Brain Imaging Behav."},{"issue":"7638","key":"10.1016\/j.bbi.2024.09.006_b0145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbi.2024.09.006_b0150","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/neu.2015.4361","article-title":"Pioglitazone attenuates neuroinflammation and promotes dopaminergic neuronal survival in the nigrostriatal system of rats after diffuse brain injury","volume":"34","author":"Liu","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bbi.2024.09.006_b0155","doi-asserted-by":"crossref","unstructured":"Liu, Y., Guo, C., Ding, Y., Long, X., Li, W., Ke, D., Wang, Q., Liu, R., Wang, J.-Z., Zhang, H., Wang, X., 2020. Blockage of AEP attenuates TBI-induced tau hyperphosphorylation and cognitive impairments in rats. Aging, 12(19), 19421\u201319439. 10.18632\/aging.103841.","DOI":"10.18632\/aging.103841"},{"issue":"1\u20133","key":"10.1016\/j.bbi.2024.09.006_b0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-5793(02)03487-7","article-title":"Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3\u03b2","volume":"530","author":"Liu","year":"2002","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.bbi.2024.09.006_b0165","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bbrc.2016.03.003","article-title":"Rosiglitazone attenuates inflammation and CA3 neuronal loss following traumatic brain injury in rats","volume":"472","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbi.2024.09.006_b0170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1471-4159.2006.03758.x","article-title":"Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-\u03b3 agonist rosiglitazone","volume":"97","author":"Luo","year":"2006","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.bbi.2024.09.006_b0175","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrd2111","article-title":"Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases","volume":"6","author":"Mazanetz","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbi.2024.09.006_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104611","article-title":"Pioglitazone improves working memory performance when administered in chronic TBI","volume":"132","author":"McGuire","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40478-018-0557-6","article-title":"Phosphorylation of different tau sites during progression of Alzheimer\u2019s disease","volume":"6","author":"Neddens","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"7","key":"10.1016\/j.bbi.2024.09.006_b0205","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","article-title":"Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration","volume":"19","author":"Patani","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2024.09.006_b0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pnpbp.2015.01.003","article-title":"A single dose of PPAR\u03b3 agonist pioglitazone reduces cortical oxidative damage and microglial reaction following lateral fluid percussion brain injury in rats","volume":"59","author":"Pilipovi\u0107","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2024.09.006_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.110918","article-title":"Rosiglitazone regulates astrocyte polarization and neuroinflammation in a PPAR-\u03b3 dependent manner after experimental traumatic brain injury","volume":"209","author":"Ren","year":"2024","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbi.2024.09.006_b0220","doi-asserted-by":"crossref","unstructured":"Robinson, C. P. (2021). Moderate and severe traumatic brain injury.","DOI":"10.1212\/CON.0000000000001036"},{"key":"10.1016\/j.bbi.2024.09.006_b0225","doi-asserted-by":"crossref","DOI":"10.1177\/1179069519844020","article-title":"Sex differences in animal models of traumatic brain injury","volume":"13","author":"Rubin","year":"2019","journal-title":"J. Exp. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0230","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.expneurol.2010.10.003","article-title":"Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury","volume":"227","author":"Sauerbeck","year":"2011","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.bbi.2024.09.006_b0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.expneurol.2011.02.002","article-title":"Broad-spectrum neuroprotection against traumatic brain injury by agonism of peroxisome proliferator-activated receptors","volume":"229","author":"Semple","year":"2011","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.bbi.2024.09.006_b0240","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3390\/ijms18081788","article-title":"The role of neurogenic inflammation in blood-brain barrier disruption and development of cerebral oedema following acute central nervous system (CNS) injury","volume":"18","author":"Sorby-Adams","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2024.09.006_b0245","doi-asserted-by":"crossref","unstructured":"Strekalova, T., Spanagel, R., Bartsch, D., Henn, F. A., & Gass, P. (2004). Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 29(11), 2007\u20132017. 10.1038\/sj.npp.1300532.","DOI":"10.1038\/sj.npp.1300532"},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0250","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jnr.24331","article-title":"Neuroinflammation and blood\u2013brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets","volume":"98","author":"Sulhan","year":"2020","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0265","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3233\/JAD-151013","article-title":"T3D\u2013959: a multi-faceted disease remedial drug candidate for the treatment of Alzheimer\u2019s disease","volume":"51","author":"Tong","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"5","key":"10.1016\/j.bbi.2024.09.006_b0270","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/biomedicines11051449","article-title":"Behavioral and psychiatric symptoms in patients with severe traumatic brain injury: A comprehensive overview","volume":"11","author":"Torregrossa","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.bbi.2024.09.006_b0275","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3171\/2017.7.JNS17878","article-title":"Brain repair by hematopoietic growth factors in the subacute phase of traumatic brain injury","volume":"129","author":"Toshkezi","year":"2018","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0280","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s13311-022-01306-8","article-title":"Tackling neuroinflammation after traumatic brain injury: complement inhibition as a therapy for secondary injury","volume":"20","author":"Van Erp","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"9","key":"10.1016\/j.bbi.2024.09.006_b0285","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/glia.23171","article-title":"Sexual dimorphism in the inflammatory response to traumatic brain injury","volume":"65","author":"Villapol","year":"2017","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2024.09.006_b0300","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbi.2022.07.164","article-title":"Early posttraumatic CSF1R inhibition via PLX3397 leads to time- and sex-dependent effects on inflammation and neuronal maintenance after traumatic brain injury in mice","volume":"106","author":"Wang","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0310","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-021-01178-7","article-title":"Mild traumatic brain injury induces microvascular injury and accelerates Alzheimer-like pathogenesis in mice","volume":"9","author":"Wu","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1517\/14728210902769601","article-title":"Emerging treatments for traumatic brain injury","volume":"14","author":"Xiong","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"5","key":"10.1016\/j.bbi.2024.09.006_b0320","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.3892\/mmr.2015.4292","article-title":"Rosiglitazone exerts neuroprotective effects via the suppression of neuronal autophagy and apoptosis in the cortex following traumatic brain injury","volume":"12","author":"Yao","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbi.2024.09.006_b0325","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2008.09.074","article-title":"PPAR\u03b3 agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms","volume":"1244","author":"Yi","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2024.09.006_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/9860855","article-title":"Neuroprotective and anti-inflammatory effects of pioglitazone on traumatic brain injury","volume":"2022","author":"Zamanian","year":"2022","journal-title":"Mediators Inflamm."},{"issue":"3","key":"10.1016\/j.bbi.2024.09.006_b0340","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.neuron.2021.10.034","article-title":"Dynamics of a disinhibitory prefrontal microcircuit in controlling social competition","volume":"110","author":"Zhang","year":"2022","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0345","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41418-020-00620-y","article-title":"RPS23RG1 modulates tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation","volume":"28","author":"Zhao","year":"2021","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.bbi.2024.09.006_b0350","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12964-020-00549-2","article-title":"Dual roles of astrocytes in plasticity and reconstruction after traumatic brain injury","volume":"18","author":"Zhou","year":"2020","journal-title":"Cell Commun. Signal."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124005981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124005981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:25:42Z","timestamp":1747866342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159124005981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":54,"alternative-id":["S0889159124005981"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.09.006","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic glial activation and behavioral alterations induced by acute\/subacute pioglitazone treatment in a mouse model of traumatic brain injury","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}